Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
Zhang R, Mamza JB, Morris T, et al.
BMC Med. 2022;20(1):63.
Leggi
Zhang R, Mamza JB, Morris T, et al.
BMC Med. 2022;20(1):63.
Leggi
Tonon F, Candido R, Toffoli B, et al.
NMCD. Pub. online 9 February 2022
Leggi
Hao Z, Sun Y, Li G, et al.
BMC Endocr Disord. 2022;22(1):37.
Leggi
Rhee JJ, Han J, Montez-Rath ME, et al.
Diabetes Obes Metab. Pub. online 3 February 2022.
Leggi
Pradhan R, Patorno E, Tesfaye H, et al.
Am J Epidemiol. 2022;kwac021.
Leggi
Birabaharan M, Kaelber DC, Pettus JH, Smith DM
Diabetes Obes Metab. Pub. online 3 February 2022.
Leggi
Yang LJ, Wu TW, Tang CH, Peng TR
BMC Endocr Disord. 2022;22(1):35.
Leggi
Masulli M, D’Elia L, Angeli F, et al.
NMCD. Pub. online 3 Febbraio 2022
Leggi
Strelitz J, Lawlor ER, Wu Y, et al.
Diabetologia. 2022;65(3):424-439.
Leggi
Maalmi H, Herder C, Bönhof GJ, et al.
Diabetologia. 2022;65(3):552-562.
Leggi